AINDEX
Markets

Quest Diagnostics Incorporated (DGX)

DGXNYSEMedical Specialities

$259.26

-0.4150 (-0.16%) today

Regular session, Nov 10, 2:05 PM ET

-0.16% 1D
Market cap
$28.52bn
P/E
23.5
EPS, last 4 quarters
$11.04
Dividend yield
–
Day range
$254.78 to $259.69
52-week range
$171.18 to $259.84
Average volume
1.34m
Previous close
$259.67

Analysts

7 covering

Buy3 buy, 4 hold, 0 sell

Targets a year out average $259.57, +0.1% from here

$250.00now $259.26$265.00

Earnings

next estimate $2.68

Next report

Dec 2025

+3.0%

Mar 2026

+5.5%

Jun 2026

+11.0%

Sep 2026

+5.3%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$2.81bn$2.90bn$3.04bn$3.10bn
Gross profit$910.00m$942.00m$1.03bn$1.04bn
Operating income$386.00m$399.00m$459.00m$479.00m
Net income$245.00m$252.00m$320.00m$312.00m

Last four quarters: revenue $11.84bn, margin 9.5%, free cash flow $1.38bn

News

8 latest

The company

Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We help connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, our insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three adult Americans each year, and our nearly 60,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com.

Sector
Health Care
Industry
Medical Specialities
Exchange
NYSE
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.